The 'Mounjaro flu' feeling: what it is and when it passes

The 'Mounjaro flu' feeling is a cluster of GI and fatigue-related side effects, not an actual influenza infection, the distinction matters practically.
Symptoms typically appear in the first few days after each new pen or dose increase, and tend to settle within one to two weeks for most people.
Dehydration is a key driver: nausea that puts you off fluids makes the headache and fatigue noticeably worse, small, regular sips make a real difference.
Persistent, severe or unusual symptoms should be discussed with your prescriber; a GLP-1 medicine does not make you more susceptible to catching the actual flu virus.

Some people starting Mounjaro (tirzepatide) describe the first week or two as feeling a bit like flu — low energy, a dull headache, mild nausea, and a general sense of being off. This reaction has a name on the forums: 'Mounjaro flu'. It is not actually influenza, and it does not mean something has gone wrong. According to the NHS medicines page for tirzepatide, nausea, fatigue, headache and dizziness are among the recognised side effects of Mounjaro, particularly during the early weeks or after a dose increase. For most people, these symptoms ease considerably once the body adjusts. Mounjaro is a prescription-only medicine, so a GPhC-registered prescriber should know about any symptoms you experience — that is what the clinical review at every stage is for.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What the 'Mounjaro flu' actually involves, why it happens, and how to get through it

You've started your pen and now you feel rough, here's what's going on

Picture the scene: your Mounjaro pen arrived in its plain DPD box, you did your first injection, and two days later you feel like you've been flattened. Head a bit heavy, stomach unsettled, no appetite even beyond the medicine's intended effect, and an urge to lie on the sofa. This is the 'Mounjaro flu' that people describe in weight-loss communities, and it is almost entirely explained by how tirzepatide works on your gut.

Tirzepatide is a dual GIP and GLP-1 receptor agonist, meaning it activates two gut-hormone pathways simultaneously. One of those effects is slowing how quickly the stomach empties food. That mechanism is central to why the medicine reduces appetite, but in the early days it can also create a persistent sense of fullness, nausea, and the kind of low-grade malaise that gets labelled as flu-like. Add a headache triggered by mild dehydration (common when nausea puts you off drinking enough), and the picture looks convincingly flu-ish even though no virus is involved.

The NHS tirzepatide page lists nausea, fatigue, headache and dizziness as common side effects, particularly when starting treatment or moving up a dose. The 2.5 mg starting pen exists specifically to give your body time to adjust before reaching therapeutic doses, the titration schedule is a deliberate buffer, not a delay. Most people find these feelings are at their sharpest in the 24 to 72 hours after injection, then fade as the week goes on. For practical questions about what to expect at each stage, the full breakdown of what causes this feeling covers the mechanism in more detail.

Does feeling like this mean Mounjaro isn't agreeing with you?

Not necessarily. The 'Mounjaro flu' experience is genuinely common, especially in the first one to two weeks at a new dose. It does not mean your body is rejecting the medicine or that you should stop. What it usually means is that your system is adjusting to a significant change in how the gut processes food and signals hunger.

The distinction worth holding on to: this is a side-effect response to the medicine itself, not evidence that you have caught flu or that your immune system is compromised. A GLP-1 or dual-agonist medicine does not make you more likely to pick up a respiratory virus, there is no known mechanism by which tirzepatide increases infection susceptibility. If you are wondering how Mounjaro interacts with an actual bout of flu, the guidance on taking Mounjaro when you genuinely have the flu addresses that separately.

The symptoms worth watching closely are the ones that break the pattern: severe stomach pain that radiates to the back (which can indicate pancreatitis and warrants prompt medical assessment), signs of significant dehydration such as very dark urine or dizziness on standing, or any allergic reaction. In January 2026 the MHRA issued a Drug Safety Update specifically highlighting acute pancreatitis as an infrequent but serious risk with GLP-1 medicines, their Yellow Card scheme lets you report any suspected side effect directly. For side effects that sit in the uncomfortable-but-expected zone, the advice is to manage them actively rather than push through in silence.

Practical ways to reduce the roughest days

Small adjustments make a measurable difference. Staying hydrated is the highest-leverage thing you can do: because nausea makes you reluctant to drink, it sets off a cycle where dehydration then worsens the headache and fatigue. Sipping water or a diluted electrolyte drink steadily throughout the day is more manageable than trying to hit a glass at a time.

Eating patterns matter too. Large meals put extra strain on a stomach that is already emptying slowly, smaller portions, soft foods, and avoiding very high-fat or very rich food in the first few days after a new injection tends to reduce nausea. Cold or room-temperature food is often better tolerated than hot. Ginger (in tea or biscuit form) has a reasonable evidence base for mild nausea, and many patients find it helpful without any interaction risk.

Timing the injection can also shift where in the week the roughest hours fall, some people prefer injecting in the evening so the worst of the 24-hour peak happens during sleep. This is worth discussing with your prescriber if the timing is affecting work or daily life. For a broader look at all the things worth knowing before your first pen, the Mounjaro overview page covers the full picture in one place.

If symptoms are severe, persistent beyond two weeks at a given dose, or getting worse rather than improving, tell your prescriber rather than trying to manage alone. The 'Mounjaro flu' phase should be temporary. A question our prescribers hear most weeks is whether feeling this rough is normal, the honest answer is that mild-to-moderate discomfort is common, but severe or lasting symptoms are always worth flagging. You can also read about how Mounjaro compares to feeling run-down for other reasons, including on the effect on hangovers, where gastric slowing is again the mechanism.

When to get medical help, and the line between side effects and something more serious

Most people move through the Mounjaro flu phase without needing anything beyond patience and hydration. But some symptoms should prompt a call to your GP or 111 rather than waiting it out.

Get medical help promptly if you experience: severe abdominal pain, especially if it radiates toward your back; repeated vomiting that stops you keeping fluids down for more than a day; signs of an allergic reaction such as swelling of the face, lips or throat, a rash, or difficulty breathing; or any sudden change in vision. Pancreatitis (though infrequent) is a genuine risk with this class of medicine, and the symptom pattern (severe, persistent, radiating stomach pain) is distinct from ordinary nausea.

Ordinary 'Mounjaro flu' symptoms, on the other hand, stay in the GI and fatigue zone, tend to follow the injection timing, and ease as the week progresses. The fact that they're unpleasant does not make them dangerous. If you are on Mounjaro and also need to consider a flu vaccine, there is specific guidance on the flu jab and Mounjaro interaction, a common and sensible question this time of year.

For general information about tirzepatide as a medicine, the tirzepatide guide gives a full clinical overview. And if the way treatment is priced is on your mind, the weight-loss treatments page sets out exactly what is included with a private prescription at nume, there are no hidden extras. If you have questions about your own experience on Mounjaro, speaking to our prescribers is the right next step.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions